Patients with psoriasis and psoriatic arthritis who received methotrexate were more likely to develop liver disease compared to patients with rheumatoid arthritis, independent of other major risk factors, Conservative hepatotoxicity monitoring may be warranted in patients receiving methotrexate for psoriatic…

Continue Reading